Search alternatives:
largest decrease » marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
Showing 1 - 20 results of 6,372 for search '(( ((i values) OR (_ values)) decrease ) OR ( c ((largest decrease) OR (larger decrease)) ))', query time: 0.77s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    TITAN thresholds and percentile estimates for benthic macroinvertebrate and diatom communities deemed to be sensitive decreasers or tolerant increasers. The thresholds represent the largest fsum <i>z</i> value in the main data analysis run (i.e., the median), whereas the 5<sup>th</sup> and 95<sup>th</sup> percentile change points are determined from 500 bootstrap replicate runs.... by Brent J. Bellinger (21156150)

    Published 2025
    “…<p>TITAN thresholds and percentile estimates for benthic macroinvertebrate and diatom communities deemed to be sensitive decreasers or tolerant increasers. The thresholds represent the largest fsum <i>z</i> value in the main data analysis run (i.e., the median), whereas the 5<sup>th</sup> and 95<sup>th</sup> percentile change points are determined from 500 bootstrap replicate runs. …”
  6. 6
  7. 7
  8. 8

    The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness. by Gui Araujo (22170819)

    Published 2025
    “…When they stop being introduced in further assembly events (i.e. introduced species do not carry any mutualistic interactions), their proportion slowly decreases with successive invasions. …”
  9. 9

    Biases in larger populations. by Sander W. Keemink (21253563)

    Published 2025
    “…<p>(<b>A</b>) Maximum absolute bias vs the number of neurons in the population for the Bayesian decoder. Bias decreases with increasing neurons in the population. …”
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    The multiple criteria qualitative value-based pricing framework “MARIE” for new clinical status by Akina Takami (16407200)

    Published 2025
    “…However, the failure to incorporate a drug’s value when determining its price decreases pharmaceutical companies’ motivation to develop and launch novel drugs in Japan.…”
  17. 17
  18. 18
  19. 19
  20. 20